Tuesday, January 3, 2017

Lonza concludes peptides business sale, books charges

ZURICH, Jan 4 (Reuters) - Lonza has concluded the

divestment of its peptides business in Belgium to PolyPeptide

Laboratories Holding, the Swiss group said on Wednesday. It gave

no financial terms.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)